Literature DB >> 24121783

Retrospective analysis of the clinical course for intubation vs. unspecified laryngeal granulomas.

Yoshihiko Kumai, Eiji Yumoto, Kohei Nishimoto, Ryosei Minoda.   

Abstract

Intubation laryngeal granulomas (ILGs) are a well-known complication of endotracheal intubation. Cases other than ILGs can be categorized as unspecified laryngeal granulomas (ULGs) since their etiologies are often difficult to confirm. We intended to clarify clinical features of both ILGs and ULGs and that anticoagulant medication could cause the formation and delayed healing of ILGs in terms of wound-healing delay. We compared the results of our treatment of ILGs (n = 16) and ULGs (n = 47) treated between 1998 and 2009 to characterize these patients. The clinical course, treatment (medical vs. surgical), indications for surgical resection, treatment outcome, and use of anticoagulants for preexisting disease were reviewed and compared between these two groups. The resolution rate was significantly better in ILGs (p < .05). Five ILGs and seven ULGs were surgically resected. The main reason for resection was airway obstruction and the need for histological assessment, respectively. The use of anticoagulants was significantly higher in ILGs than ULGs (8/16 vs. 4/47, p < .01). The resolution period was significantly longer in the ILGs patients with anticoagulant medication compared to that in the ILGs patients without anticoagulant medication (152 ± 101 days vs. 76 ± 44 days, p < .05). ILGs may have different clinical course from ULGs, especially in terms of the resolution period. Moreover, administration of anticoagulants may deter healing of small injury due to intubation. Patients taking anticoagulants should be managed carefully during the perioperative period to prevent the occurrence of ILGs.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24121783     DOI: 10.1007/s00405-013-2760-1

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  16 in total

1.  A retrospective study of contact granuloma.

Authors:  R Ylitalo; P A Lindestad
Journal:  Laryngoscope       Date:  1999-03       Impact factor: 3.325

2.  Peptic (contact ulcer) granuloma of the larynx.

Authors:  T L Miko
Journal:  J Clin Pathol       Date:  1989-08       Impact factor: 3.411

3.  Complications associated with warfarin prophylaxis in total knee arthroplasty.

Authors:  C J Sutherland; J R Schurman
Journal:  Clin Orthop Relat Res       Date:  1987-06       Impact factor: 4.176

4.  Wound healing in acute spinal cord injury: effect of anticoagulation.

Authors:  J H Frisbie
Journal:  Arch Phys Med Rehabil       Date:  1986-05       Impact factor: 3.966

Review 5.  Basics of cutaneous wound repair.

Authors:  R A Clark
Journal:  J Dermatol Surg Oncol       Date:  1993-08

6.  Contact ulcers and granulomas of the larynx: new insights into their etiology as a basis for more rational treatment.

Authors:  P H Ward; D Zwitman; D Hanson; G Berci
Journal:  Otolaryngol Head Neck Surg (1979)       Date:  1980 May-Jun

7.  Importance of glottic configuration in the development of posterior laryngeal granuloma.

Authors:  P Pontes; N De Biase; L Kyrillos; A Pontes
Journal:  Ann Otol Rhinol Laryngol       Date:  2001-08       Impact factor: 1.547

Review 8.  Vocal process granuloma.

Authors:  H T Hoffman; E Overholt; M Karnell; T M McCulloch
Journal:  Head Neck       Date:  2001-12       Impact factor: 3.147

9.  Hyperfunctional, hyperacidic, and intubation granulomas.

Authors:  R J Feder; M J Michell
Journal:  Arch Otolaryngol       Date:  1984-09

10.  Vocal process granuloma: clinical characterization, treatment and evolution.

Authors:  Elza Maria Lemos; Luiz Ubirajara Sennes; Rui Imamura; Domingos H Tsuji
Journal:  Braz J Otorhinolaryngol       Date:  2005-12-15
View more
  1 in total

1.  A Case of Laryngeal Granulomas After Oral and Maxillofacial Surgery With Prolonged Intubation.

Authors:  Masanori Tsukamoto; Shiori Taura; Takashi Hitosugi; Takeshi Yokoyama
Journal:  Anesth Prog       Date:  2021-06-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.